coding direction for covid-19 — part 2: a comprehensive review

Coding Direction for COVID-19 —Part 2: A Comprehensive Review

Presenter: Margaret PenchoffModerator: Kristy MabonClassifications and TerminologiesCanadian Institute for Health Information

May 26, 2021 [email protected] cihi.ca @cihi_icis

mailto:[email protected]

https://www.cihi.ca/en

https://twitter.com/cihi_icis


2

Collaboration with World Health Organization (WHO)

3

Learning objectivesAfter attending this webinar, you will be able to

• Correctly classify COVID-19–related episodes of care to codes U07.1 to U07.7‒ Confirmed (U07.1) and suspected (U07.2) COVID-19

‒ COVID-19–related multisystem inflammatory syndrome (MIS) (U07.3)

‒ Post COVID-19 condition (U07.4)

‒ Personal history of COVID-19 (U07.5)

‒ Vaccination against COVID-19 (U07.6)

‒ Adverse reaction due to a COVID-19 vaccine (U07.7)

• Identify available resources

4

Coding Standards Version 2018 Addendum

5

Canadian Coding Standards•Canadian Coding Standards for Version 2018 ICD-10-CA and

CCI — Addendum: Pandemics and Epidemics (COVID-19) contains new direction

When a new pandemic or epidemic condition is declared, wait for communication from CIHI that provides the unique and specific code(s) before classifying the case.• Assign the unique and specific code for a condition declared

a pandemic or epidemic per direction from CIHI.

6

Canadian Coding Standards•Canadian Coding Standards for Version 2018 ICD-10-CA and

CCI — Addendum: Pandemics and Epidemics (COVID-19)‒ Consolidates all coding direction released in bulletins over the past year

‒ Includes a COVID-19 section with directive statements and examples demonstrating application of directive statements for U07.1, U07.2, U07.3, U07.4, U07.5, U07.6 and U07.7

‒ In effect 2021–2022

‒ Will be incorporated into the Canadian Coding Standards Version 2022

7

Job Aid: ICD-10-CA/CCI COVID-19 Episodes of Care• Accompanies the Pandemics and Epidemics coding standard• Quick reference that includes

‒ COVID-19–related codes, code titles, coding direction, alphabetical index and tabular list

‒ Interim CCI v2018 COVID-19 vaccination code

• Download the job aid from the Codes and Classifications web page

https://www.cihi.ca/sites/default/files/document/icd-10-ca-cci-covid-19-episodes-of-care-jobaid-en.pdf

8

Confirmed COVID-19U07.1 COVID-19, virus identified

Assign U07.1 COVID-19, virus identified, mandatory, regardless of significance, when acute infection due to the COVID-19 virus is confirmed by a positive COVID-19 lab test result.

• Confirmed COVID-19• Positive COVID-19 lab test result• Positive lab test result indicates the

patient has an acute infection with COVID-19 [SARS-CoV-2] virus

9

Suspected COVID-19 U07.2 COVID-19, virus not identified

Assign U07.2 COVID-19, virus not identified, mandatory, regardless of significance, when there is a final diagnosis of (suspected) COVID-19 and the COVID-19 lab test result is inconclusive or not available, or testing is not performed. Do not assign U07.2 when COVID-19 is ruled out by a negative COVID-19 lab test result.

• Suspected COVID-19• Diagnosed clinically or

epidemiologically and lab test results are inconclusive or not available, or testing isnot performed

• Do not apply prefix Q• Do not assign U07.2 if ruled out

10

Use of COVID-19 lab test results for coding

Applies to abstracts submitted to the DAD

and NACRS

Use COVID-19 lab test results to inform code

assignment when physician or infection

control documentation of the COVID-19 lab test results is not available

Use the most recent COVID-19 lab test results

from a continuous, uninterrupted episode of

care, when available, to confirm or rule

out COVID-19

It is recommended that coders flag coded charts

and update once lab results become available

Exception to the direction provided in coding standard Using Diagnostic Test Results in Coding

11

COVID-19: Confirmed and suspected

• Patient is admitted with suspected COVID-19 and acute respiratory distress syndrome (ARDS)

• COVID-19 lab test result returns positive• Final diagnosis: COVID-19 positive, ARDS, pneumonia

Scenario

• U07.1 (M) COVID-19, virus identified• J80 (1) Adult respiratory syndrome• J12.8 (1) Other viral pneumonia

Code assignment

12


• Patient is seen in the emergency department• COVID-19 lab test result comes back negative• Final diagnosis: Viral respiratory illness, ? COVID-19

Scenario

• B34.9 (MP) Viral infection, unspecifiedCode assignment

13


• Pregnant patient presents at 35 weeks gestation with dyspnea, fever• Positive COVID-19 lab test 8 days ago• Patient is admitted• Final diagnosis: COVID-19 pneumonia

Scenario

• O98.503 (M) Other viral diseases complicating pregnancy, childbirth and the puerperium, antepartum condition or complication

• U07.1 (3) COVID-19, virus identified• O99.503 (1) Diseases of the respiratory system complicating

pregnancy, childbirth and the puerperium, antepartum condition or complication

• J12.8 (3) Other viral pneumonia

Code assignment

COVID-19How can clinicians help ensure that data supports monitoring?

Clearly document COVID-19 as

SuspectedCOVID-19

Laboratory result inconclusive or not available at time of discharge, or testing not performed (diagnosed

clinically or epidemiologically)

ConfirmedCOVID-19

Positive laboratory result

© 2020 Canadian Institute for Health Information

Knowledge check 1

16

Knowledge check 1: Scenario

Facts› Patient is seen in emergency department with cough and

general unwell feeling

› Patient was exposed to COVID-19

› COVID-19 lab test is not performed

Final diagnosis: Suspected COVID-19

17

Knowledge check 1: Question and options

Which code is assigned as the main problem?a) Prefix (Q) U07.1 (MP) COVID-19, virus identified

b) Prefix (Q) U07.2 (MP) COVID-19, virus not identified

c) R05.0 (MP) Cough

d) U07.1 (MP) COVID-19, virus identified

e) U07.2 (MP) COVID-19, virus not identified

18

Knowledge check 1: Answer and rationaleAnswere) U07.2 (MP) COVID-19, virus not identified

Rationale Diagnosis is suspected COVID-19; it was not ruled out.

COVID-19 was not confirmed by a positive COVID-19 lab test.

U07.2 is assigned when diagnosis is suspected (or similar terminology) COVID-19 and has not been ruled out.

Prefix Q is not applied to U07.2.

Knowledge check 2

20

Knowledge check 2: ScenarioFacts

› Patient has COVID-19 swab taken at assessment center

› Patient is referred to emergency department with severe dyspnea

› Physician calls assessment center for COVID-19 test results — COVID-19 lab test result is positive

Final diagnosis: COVID-19

21


Which code is assigned as the main problem?a) R06.0 (MP) Dyspnoea

b) U07.1 (MP) COVID-19, virus identified

c) U07.2 (MP) COVID-19, virus not identified

22

Knowledge check 2: Answer and rationaleAnswerb) U07.1 (MP) COVID-19, virus identified

Rationale Patient had COVID-19 testing done at assessment center.

Physician verified that COVID-19 lab test result was positive.

COVID-19 lab test results from a continuous, uninterrupted episode of care, when available, can be used to confirm or rule out COVID-19.

COVID-19 confirmed by positive lab test result.

23

MIS associated with COVID-19U07.3 Multisystem inflammatory syndrome associated with COVID-19

When the physician/primary care provider documents a diagnosis synonymous with multisystem inflammatory syndrome associated with COVID-19, assign, mandatory, U07.3 Multisystem inflammatory syndrome associated with COVID-19, regardless of significance.

• MIS temporally associated with COVID-19

• Diagnosed in children and adults• Includes: Cytokine storm

(syndrome), Kawasaki-like syndrome, pediatric inflammatory multisystem syndrome (PIMS) and multisystem inflammatory syndrome in children (MIS-C)

24

COVID-19–related multisystem inflammatory syndrome (MIS)

• Patient is admitted to the intensive care unit (ICU) with acute respiratory distress syndrome (ARDS); requires intubation and mechanical ventilation

• COVID-19 swab comes back positive for COVID-19 [SARS-CoV-2]• Cytokine storm is identified with elevations in biomarkers• Patient is treated with tocilizumab, which results in predicted

decrease in biomarkers; patient’s condition improves• Final diagnosis: COVID-19, cytokine storm, ARDS

Scenario

• U07.1 (M) COVID-19, virus identified• U07.3 (1) Multisystem inflammatory syndrome associated

with COVID-19• J80 (1) Adult respiratory distress syndrome

Code assignment

Knowledge check 3

26


› Pediatric patient is admitted with gastroenteritis, rash, bilateral eye erythema, coryza, high temperature (>39°) with thrombocytosis

› COVID-19 swab comes back positive for COVID-19› Fever dissipates but diarrhea and rash persist› Seen in consultation by rheumatology

and cardiology

Final diagnosis: COVID-19 infectionIncomplete Kawasaki syndrome

27

Knowledge check 3: Question and optionsWhich codes are assigned?

a) U07.1 (M) COVID-19, virus identified only

b) U07.1 (M) COVID-19, virus identified and M30.3 (1) Mucocutaneous lymph node syndrome [Kawasaki]

c) U07.1 (M) COVID-19, virus identified and U07.3 (1) Multisystem inflammatory syndrome associated with COVID-19

d) U07.3 (M) Multisystem inflammatory syndrome associated with COVID-19 only

28

Knowledge check 3: Answer and rationaleAnswerc) U07.1 (M) COVID-19, virus identified and U07.3 (1) Multisystem

inflammatory syndrome associated with COVID-19

Rationale The patient was diagnosed with confirmed COVID-19 and incomplete

Kawasaki syndrome in the context of COVID-19 infection. Kawasaki-like syndrome (temporally associated with COVID-19) is an

inclusion at U07.3. U07.1 and U07.3 are assigned to identify the acute COVID-19

infection and the manifestation incomplete Kawasaki syndrome.

29

Post COVID-19 conditionU07.4 Post COVID-19 condition

When the physician/primary care provider documents a relationship between or association with a specific condition(s) or symptom(s) and past COVID-19 (i.e., resolved acute COVID-19 infection), assign, mandatory, regardless of significance,• A code for the specific condition(s) or

symptoms(s) and apply prefix 7; and• U07.4 Post COVID-19 condition as a

diagnosis type (3)/other problem.

• Documented relationship between or association with specific condition(s) or symptom(s) and past (resolved) COVID-19

• Always apply diagnosis type (3)/other problem to U07.4

• Assign ICD-10-CA code(s) for specific condition(s) or symptom(s) and apply prefix 7 to these code(s)

30

Post COVID-19 condition

• Patient presents with worsening respiratory failure• Diagnosed with COVID-19 pneumonia 1 month previously• COVID-19 swabs are negative• Admitted to intensive care unit (ICU) on 5 liters oxygen• Computerized tomography (CT) scan confirms bilateral

pulmonary fibrosis• Started on dexamethasone• Final diagnosis: Pulmonary fibrosis post COVID-19

Scenario

• Prefix (7) J84.1 (M) Other interstitial pulmonary diseases with fibrosis• U07.4 (3) Post COVID-19 condition (mandatory)Code assignment

COVID-19

© 2021 Canadian Institute for Health Information

How can clinicians help ensure that data supports

monitoring for post COVID-19 conditions?

Clinical scenarioA specific diagnosis or symptom is presumed (or determined) to be associated with post acute COVID-19 infection.

Suggested documentation

Document the final diagnosis or symptom to describe its relationship with post acute COVID-19 infection.

The clinical definition of post COVID-19 conditions is evolving and includes many diagnoses. Some examples are

Post COVID-19 viral cough

DVT secondary to past COVID-19

Early pneumonia/post COVID-19

Persistent fatigue related to past COVID-19

Knowledge check 4

33


› Patient is admitted for treatment of multisystem inflammatory syndrome in children (MIS-C)

› History of COVID-19 infection

› COVID-19 swab comes back negative

Final diagnosis: Multisystem inflammatory syndrome in children

34


a) Prefix (7) U07.3 (M) Multisystem inflammatory syndrome associated with COVID-19 andU07.4 (3) Post COVID-19 condition

b) U07.3 (M) Multisystem inflammatory syndrome associated with COVID-19 and U07.1 (1) COVID-19, virus identified

c) U07.3 (M) Multisystem inflammatory syndrome associated with COVID-19 andU07.2 (1) COVID-19, virus not identified

35

Knowledge check 4: Answer and rationaleAnswera) Prefix (7) U07.3 (M) Multisystem inflammatory syndrome associated

with COVID-19 and U07.4 (3) Post COVID-19 condition

Rationale Diagnosis is multisystem inflammatory syndrome in children.

Documented history of COVID-19 infection.

COVID-19 swab came back negative.

No documentation of current acute infection with COVID-19 virus.

36

Personal history of COVID-19U07.5 Personal history of COVID-19

When there is documentation indicating a history of COVID-19, whether confirmed or suspected, assign U07.5 Personal history of COVID-19, mandatory, as a diagnosis type (3)/other problem.

• Documentation indicating the patient had (a history of) COVID-19

• Always apply diagnosis type (3)/other problem to U07.5

37

Personal history of COVID-19

• Patient presents to the emergency department with back pain radiating around lower abdomen

• Denies urinary symptoms• Positive COVID-19 test 46 days prior to this episode of care• No signs or symptoms of COVID-19• Computerized tomography (CT) scan is normal • Final diagnosis: Back pain

Scenario

• M54.9 (MP) Dorsalgia, unspecified site• U07.5 (OP) Personal history of COVID-19 (mandatory)

Code assignment

38

Post COVID-19 condition versus personal history

• Patient had COVID-19• Acute COVID-19 infection resolved• Documentation supporting relationship/association with specific

condition(s)/symptom(s) and past (resolved) COVID-19

Post COVID-19

• Patient had COVID-19• Acute COVID-19 infection resolved• Documentation indicating patient had (a history of) COVID-19

Personal history of COVID-19

Knowledge check 5

40


› Patient presents to the emergency department for COVID-19 re-testing

› Tested positive for COVID-19 12 days previously

› Requires a negative COVID-19 test in order to return to work

› COVID-19 lab test result subsequently comes back negative

Final diagnosis: COVID-19 re-testing

41


a) Z09.9 (MP) Follow-up examination after unspecified treatment for other conditions and U07.1 (OP) COVID-19, virus identified

b) Z09.9 (MP) Follow-up examination after unspecified treatment for other conditions and U07.5 (OP) Personal history of COVID-19

c) Z09.9 (MP) Follow-up examination after unspecified treatment for other conditions and Z86.18 (OP) Personal history of other specified infectious and parasitic diseases

42

Knowledge check 5: Answer and rationaleAnswerb) Z09.9 (MP) Follow-up examination after unspecified treatment for

other conditions and U07.5 (OP) Personal history of COVID-19

Rationale Coding standard Admission for Follow-Up Examination applies.

U07.5 is mandatory (when applicable).

43

COVID-19 vaccinationU07.6 Need for immunization against COVID-19

NN When the sole purpose of the encounter is for the administration of the COVID-19 vaccine, assign U07.6 Need for immunization against COVID-19 as the main problem.

• When the sole purpose of the episode of care is to receive the COVID-19 vaccine as main problem (MP)

• Not assigned on an acute care inpatient abstract

Note: The administration of a COVID-19 vaccine is classified to an intervention. The interim CCI code is 8.FD.70.HB-BC Immunization (to prevent) COVID-19 [SARS-CoV-2] virus (CCI v2018 will not display this code title). The decision to assign 8.FD.70.HB-BC when a vaccination against COVID-19 is administered is made at the jurisdiction or facility level, based on data needs.

• Interim CCI code for COVID-19 vaccination (2021)

44

COVID-19 vaccination

• Patient presents to an ambulatory care clinic and receives the COVID-19 vaccine

Scenario

• U07.6 (MP) Need for immunization against COVID-19Code assignment

45

COVID-19 vaccination

• Patient is an acute care inpatient• Patient receives the COVID-19 vaccine

Scenario

• Note: It is a jurisdictional or facility decision to assign 8.FD.70.HB-BC Immunization (to prevent) COVID-19 [SARS-CoV-2] virus

Code assignment

Knowledge check 6

47


› Patient is admitted for coronary artery bypass graft (CABG) surgery

› Patient has a number of chronic conditions, including type 2 diabetes mellitus and chronic obstructive pulmonary disease

› During the episode of care, the patient is offered and receives the COVID-19 vaccine

Final diagnosis: Atherosclerotic heart disease

48

Knowledge check 6: Question and optionsWhich code is assigned and diagnosis type is applied to identify that the patient received the COVID-19 vaccine?

a) An ICD-10-CA code is not assignedb) U07.6 (1) Need for immunization against COVID-19c) U07.6 (2) Need for immunization against COVID-19d) U07.6 (3) Need for immunization against COVID-19

49

Knowledge check 6: Answer and rationaleAnswera) An ICD-10-CA code is not assigned

Rationale U07.6 is assigned on an ambulatory care (NACRS) abstract when the

sole purpose of the encounter is to receive the COVID-19 vaccine. U07.6 is not assigned on an acute care inpatient abstract. Administration of the COVID-19 vaccine is an intervention classified

to a CCI code. Assign 8.FD.70.HB-BC Immunization (to prevent) COVID-19

(SARS-CoV-2) virus to capture administration of the COVID-19 vaccine on an acute care inpatient (DAD) abstract only if mandated by your facility or jurisdiction.

50

Adverse reaction to COVID-19 vaccine

U07.7 COVID-19 vaccines causing adverse effects in therapeutic use

Classify an adverse reaction to a COVID-19 vaccine (i.e., a reaction to the substance/ingredients) as follows:• A code to describe the specific reaction; • U07.7 COVID-19 vaccines causing adverse effects

in therapeutic use as a diagnosis type (9)/other problem; and

• Apply the diagnosis cluster, mandatory.

• The specific reaction is documented:Assign ICD-10-CA code for specificreaction and U07.7 (9)/other problem

• Apply diagnosis cluster, mandatory

51


U07.7 COVID-19 vaccines causing adverse effects in therapeutic use

When the specific reaction is not documented (e.g., allergic reaction to the COVID-19 vaccine) assign• T80.6 Other serum reactions; • U07.7 COVID-19 vaccines causing adverse effects in

therapeutic use as a diagnosis type (9)/other problem; and • Apply the diagnosis cluster, mandatory.

• The specific reaction is notdocumented: Assign T80.6and U07.7 (9)/other problem

• Apply diagnosis cluster, mandatory

52


• Patient presents to the emergency department with rash after receiving the COVID-19 vaccine

• Final diagnosis: COVID-19 vaccine reactionScenario

• L27.0 (MP) [A] Generalized skin eruption due to drugs and medicaments

• U07.7 (OP) [A] COVID-19 vaccines causing adverse effects in therapeutic use

Code assignment

53

Adverse reaction due to COVID-19 vaccineICD-10-CA alphabetical indexRash R21– drug (internal use) L27.0

– following immunization T88.1

– serum (prophylactic) (therapeutic) T80.6

54

Adverse reaction due to COVID-19 vaccine

• ICD-10-CA tabular list

55


• Patient presents to the emergency department feeling unwell after receiving the COVID-19 vaccine

• Final diagnosis: Reaction to COVID-19 vaccineScenario

• T80.6 (MP) [A] Other serum reactions• U07.7 (OP) [A] COVID-19 vaccines causing adverse effects in

therapeutic useCode assignment

56


ICD-10-CA alphabetical indexReaction (see also Disorder) – allergic (see also Allergy) T78.4– – drug, medicament or biological (see Allergy, drug) – – serum T80.6

Knowledge check 7

58


› Patient received the COVID-19 vaccine the morning they present to the emergency department

› Presenting complaint is fever

Final diagnosis: Vaccination fever

59


Which codes are assigned?

a) R50.2 (MP) [A] Drug-induced fever and U07.7 (OP) [A] COVID-19 vaccines causing adverse effects in therapeutic use

b) T88.1 (MP) [A] Other complications following immunization, not elsewhere classified andR50.2 (OP) [A] Drug-induced fever andU07.7 (OP) [A] COVID-19 vaccines causing adverse effects in therapeutic use

60

Knowledge check 7: Answer and rationaleAnswera) R50.2 (MP) [A] Drug-induced fever and U07.7 (OP) [A] COVID-19

vaccines causing adverse effects in therapeutic use

Rationale Vaccination fever is classified per the coding standard Pandemics

and Epidemics (subsection Adverse reaction to a COVID-19 vaccine).

A condition that is related to the substance that was administered is an adverse effect in therapeutic use.

Knowledge check 8

62


› Patient received COVID-19 vaccine 28 days ago

› Seen in the emergency department

› Erythema at injection site

Final diagnosis: Vaccine reaction

63


a) L53.9 (MP) [A] Erythematous condition, unspecified and U07.7 (OP) [A] COVID-19 vaccines causing adverse effects in therapeutic use

b) T88.1 (MP) [A] Other complications following immunization, not elsewhere classified and L53.9 (OP) [A] Erythematous condition, unspecified and Y84.8 (OP) [A] Other medical procedure as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

64

Knowledge check 8: Answer and rationaleAnswerb) T88.1 (MP) [A] Other complications following immunization,

not elsewhere classified and L53.9 (OP) [A] Erythematous condition, unspecified and Y84.8 (OP) [A] Other medical procedure as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

Rationale Vaccine reaction at injection site (specified as erythema) is classified

per the direction in the coding standard Post-Intervention Conditions. A condition that is related to the act of administering the substance

is a post-intervention condition.

65

Data quality

66

Open-year data quality tests: DADOYDQ test number OYDQ test title Short description

D1001-183 Missing Diagnosis Prefix 7 When U07.4 Post COVID-19 condition and a code from A00–T98 or U07.3 is assigned on an abstract, there must also be diagnosis prefix 7 assigned to at least one code from A00–T98 or U07.3 on the abstract.

D1001-184 Prefix 7 Assigned to an ICD-10-CA Code That Is Not A00–T98 or U07.3

Prefix 7 must be assigned to a code(s) from A00–T98 or U07.3.

D1002-181 U07.4 Post COVID-19 condition Without a Code From A00–T98 or U07.3

When U07.4 Post COVID-19 condition is assigned, there must be at least one other ICD-10-CA code from A00–T98 or U07.3 with prefix 7 recorded on the same abstract

D1002-182 Missing Diagnosis Code U07.4 Post COVID-19 condition

When diagnosis prefix 7 is assigned to an ICD-10-CA code from A00–T98 or U07.3, there must also be U07.4 Post COVID-19 condition recorded on the abstract.

D1004-185 U07.4 Post COVID-19 condition Assigned Diagnosis Type M, 1, 2, W, X, Y

When U07.4 Post COVID-19 condition is assigned on an abstract, the diagnosis type must be (3).

67

Open-year data quality tests: NACRSOYDQ test number OYDQ test title Short description

N0043-183 Missing Diagnosis Prefix 7 When U07.4 Post COVID-19 condition and a code from A00–T98 or U07.3 is assigned on an abstract, there must also be diagnosis prefix 7 assigned to at least one code from A00–T98 or U07.3 on the abstract.

N0043-184 Prefix 7 Assigned to an ICD-10-CA Code That Is Not A00–T98 or U07.3

Prefix 7 must be assigned to a code(s) from A00–T98 or U07.3.

N0045-181 U07.4 Post COVID-19 condition Without a Code From A00–T98 or U07.3

When U07.4 Post COVID-19 condition is assigned, there must be at least one other ICD-10-CA code from A00–T98 or U07.3 with prefix 7 recorded on the same abstract.

N0045-182 Missing Diagnosis Code U07.4 Post COVID-19 condition

When diagnosis prefix 7 is assigned to an ICD-10-CA code from A00–T98 or U07.3, there must also be U07.4 Post COVID-19 condition recorded on the abstract.

N0044-185 U07.4 Post COVID-19 condition Assigned as Main Problem

When U07.4 Post COVID-19 condition is assigned on an abstract, it must be assigned as Other Problem

68

DAD edits effective 2021–2022•New COVID-19–related edits

– 10 01 05: If the diagnosis prefix is 7, the diagnosis code must be from A00–T98 or U07.3

– 10 02 16: If there is a diagnosis code from A00–T98 or U07.3 with diagnosis prefix 7, then diagnosis code U07.4 must be recorded on the same abstract

– 10 02 16: If diagnosis code U07.4 is recorded, then there must be at least one other diagnosis code from A00–T98 or U07.3 with the diagnosis prefix 7

69

NACRS edits effective 2021–2022•New COVID-19–related edits

– 4454: If the main problem prefix is 7, the main problem must be from A00–T98 or U07.3– 4455: If the main problem is A00–T98 or U07.3 with main problem prefix 7, then there

must be an other problem U07.4 recorded on the same abstract– 45a–i50: If other problem U07.4 is coded, then main or other problem from A00–T98 or

U07.3 with the main or other problem prefix 7 must be recorded on the same abstract– 45a–i51: If an other problem is A00–T98 or U07.3 with other

problem prefix 7, then an other problem of U07.4 must be recorded on the same abstract

– 45a–i52: If the other problem prefix is 7, an other problem must be coded from A00–T98 or U07.3

70

Resources

71

Resources•CIHI’s COVID-19 resources web page (COVID-19 data collection

and coding direction) or the Codes and Classifications web page– Addendum to the Canadian Coding Standards for Version 2018 ICD-10-CA and CCI

– Job aid

– COVID-19 webinar — Part 1 (May 29, 2020)

– Infographics (for clinicians)

• eQuery

https://www.cihi.ca/en/covid-19-resources

72

Contact us

•There are a number of coding questions in eQuery‒ Search on the keyword “COVID”

‒ If the answer does not cover the circumstance you have encountered, submit a coding question and a de-identified copy of the pertinent clinical documentation for the specific case

•Send questions that are not case specific or that pertain to content covered during the webinar to [email protected]


@cihi_icis [email protected] cihi.ca

https://twitter.com/cihi_icis



coding direction for covid-19 — part 2: a comprehensive review

Documents